Results 181 to 190 of about 9,500,261 (386)
CLCN4‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities
ABSTRACT Speech and language difficulties are a core feature of the CLCN4‐related neurodevelopmental condition, but these have not been well described. Here we systematically phenotype speech and language in 13 participants (10 female, aged 1 year 10 months–41 years 10 months) with pathogenic CLCN4 variants (12 missense de novo, 1 premature stop codon ...
Alexandra Garrett +4 more
wiley +1 more source
Electrophysiological and Imaging Biomarkers to Evaluate Exercise Training in Patients with Neuromuscular Disease: A Systematic Review. [PDF]
Pomp L +3 more
europepmc +1 more source
Neuromuscular function of the human lower oesophageal sphincter in reflux disease and Barrett's oesophagus [PDF]
Scott D. Smid
openalex +1 more source
ABSTRACT The National Institute of Health (NIH) Undiagnosed Diseases Program (UDP) is an NIH project with the goal of providing both a comprehensive diagnosis and a better understanding of the many mechanisms of disease for patients with rare and undiagnosed conditions.
Dee Adedipe +19 more
wiley +1 more source
Phosphomannosyl receptors of lysosomal enzymes of skeletal muscle in neuromuscular diseases
Antero Salminen +3 more
openalex +1 more source
Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases [PDF]
Vinay Chaudhry +4 more
openalex +1 more source
ABSTRACT Autism spectrum disorder (ASD) is a neurodevelopmental condition that is increasingly linked to immune dysfunction and neuroinflammation. Regulatory T cells (Tregs), which are crucial in maintaining immune homeostasis, have been implicated in the pathogenesis of ASD.
Zuqing Nie +9 more
wiley +1 more source
Respiratory Insufficiency in Neuromuscular Disease (RIND): A Delphi Study to Establish Consensus Criteria to Define and Diagnose Hypoventilation in Pediatric Neuromuscular Disease. [PDF]
Mayer OH +5 more
europepmc +1 more source
Objective Tofersen is the first effective and approved therapy for superoxide dismutase 1 (SOD1)‐associated amyotrophic lateral sclerosis (ALS [SOD1‐ALS]). Following treatment with tofersen, neurofilament levels in patients' cerebrospinal fluid (CSF) and serum seem to respond earlier than clinical parameters.
Christina Steffke +36 more
wiley +1 more source

